Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Long-term follow-up of psilocybin-facilitated smoking cessation.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Reports from the same study

Selected source-checked relationships. Keep these records separate, but do not count each report as an independent study or add their participant totals.

Johns Hopkins smoking cessation pilot cohort

The 2017 report follows the original 15-person pilot. Do not combine their sample sizes as independent cohorts. The later randomized smoking trial is separate. Checked 2026-11-03.

Coverage is incomplete. Missing links do not establish independence. Relationship data and source evidence (JSON).

Read this study in context

This report is included in a selected evidence comparison. Review its population, primary endpoint, findings and limitations alongside the other selected reports.

These original educational annotations are not an exhaustive systematic review or a clinical guideline.

Bibliographic context

Journal
The American journal of drug and alcohol abuse
Date
2017-01-01
Source
PubMed
DOI
10.3109/00952990.2016.1170135
PubMed
27441452
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:27 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Study participant perceptions of the relevance of therapist and study team personal psychedelic experience2026-10-03Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders2026-09-02Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits2026-07-01Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex2026-06-01Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration2026-04-10Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons2026-03-27Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26Psilocybin or Nicotine Patch for Smoking Cessation2026-03-10Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency2025-12-11Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy2025-11-02Is there mush-room to improve the environmental sustainability of psilocybin production?2025-06-10Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling2025-06-01Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis2025-04-24Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?2025-03-21

Related papers

No close related records were found yet.